Several studies reported that the hexanucleotide expansion of a non-coding region within the C9orf72 gene (9p21.2) leads to the development of ALS and/or FTD with variable clinical expression and age-dependent penetrance [27]. Here, C9orf72 is linked to amyotrophic lateral sclerosis.